Description
Opioid agonist therapy (OAT), which entails the provision of medications like buprenorphine/naloxone or methadone, is an evidence-based treatment option for opioid use disorder. This fact sheet provides information for health care providers about the OAT Gap Coverage Program, which is designed to provide immediate, no-cost access to OAT drugs for patients who do not have supplementary health benefit coverage.
Updated
August 1, 2024
Tags
Title and publication information
Type
Frequency
Other
Publisher / Creator Information
Subject Information
Topic
Resource Dates
Date Created
2021-12-01
Date Added
2021-12-08T20:23:59.998090
Date Modified
2024-08-01
Date Issued
2021-12-08
Audience information
Language
Identifiers
Usage / Licence
Contact
Contact Name
Alberta Health
Contact Other
Alberta Health Services Addiction Helpline 1-866-332-2322